SCHEMBL20711325

SCHEMBL20711325

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)NC2(c3ccccc3F)COC2)[C@@H](O)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20711232 0.92 — —
SCHEMBL20711234 0.92 TRPM2 (0.54) —
SCHEMBL20711235 0.89 — —
SCHEMBL20711210 0.87 TRPM2 (0.60) —
SCHEMBL22837937 0.82 — —
SCHEMBL22837886 0.82 — —
SCHEMBL20711368 0.80 TRPM2 (0.62) —
SCHEMBL20711284 0.79 TRPM2 (0.56) —
SCHEMBL20711319 0.79 TRPM2 (0.68) —
SCHEMBL20711328 0.78 NNMT (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-12-29 — — US disclosed
US-20190038656-A1 ANTHRANILYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF Memorial Slooan-Kettering Cancer Center (US) 2019-02-07 — — US disclosed
Send feedback